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There is a healthy debate raging within the medical community concerning 
the ethics of mandatory human immunodeficiency virus (HIV) testing of 
all pregnant women. In the early 1990s, prior to perinatal preventative 
treatments that are available today, an estimated 1,000 to 2,000 infants 
were born with HIV infection each year in the United States. l In 1994, 
clinical trials showed that HIV-infected women could reduce the risk of 
transmitting the virus to their babies by as much as two-thirds through 
administration of zidovudine (ZDV or AZT) during pregnancy, labor and 
delivery, and by giving the newborns AZT for the first six weeks after 
birth.2 The results of these clinical trials fueled the debate for mandatory 
testing of all pregnant women. In 1994, the Public Health Service issued 
guidelines for using AZT during pregnancy, and in 1995, published 
guidelines for routinely counseling all pregnant women about HIV and 
offering them an HIV test. As health care professionals incorporated these 
guidelines into their clinical practice, the number of children with 
perinatally acquired AIDS dropped 43% by 1996.3 Encouraged by these 
statistics, Congress mandated a study and review of the federal guidelines 
by a committee of the Institute of Medicine, an affiliate of the National 
Academy of Sciences, concerning HIV testing of all pregnant women. On 
October 14, 1998, the committee issued its report and recommended 
making HIV testing part of routine prenatal care. The committee believed 
that mandatory HIV testing of all pregnant women would save additional 
lives, especially among the minority communities, and more than pay for 
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itself by cutting the cost of caring for infected children, which can amount 
to tens of thousands of dollars annually for each child.4 The committee 
was convinced that the benefits of mandatory testing, which are prevention 
of perinatal HIV transmission and better care for infected mothers and their 
children, greatly outweigh the burdens of possible violation of the 
mother's privacy and a possible decrease in the willingness to seek 
counseling about HIV and AIDS. The potential of saving lives and the 
cost-benefit analysis has only added fuel to this current ethical controversy. 
The intended purpose of this article is three-fold: first, to examine the 
scientific evidence regarding the status of perinatal HIV prevention; second, 
to give an ethical analysis of the arguments for and against mandatory HIV 
testing of all pregnant women; and third, to determine if the federal 
guidelines should be revised to include mandatory HIV testing of all 
pregnant women and if this position is based on solid ethical principles. 
Status of Perinatal HIV Prevention 
In the United States, as of December 1997, 641,086 Americans had 
been reported with AIDS and 350,000 of them had died. The year after, the 
CDC estimated that as many as 650,000 to 900,000 Americans were living 
with HIV and at least 400,000 infections occur each year.s In 1996, 
according to the CDC, the estimated number of adults diagnosed with 
AIDS-defining opportunistic illnesses decreased for the first time, from 
61 ,300 estimated cases in 1995 to 57,200 in 1996. Also in 1996, for the 
first time, the estimated deaths among persons with AIDS declined to 
39,200 from 50,700 in 1995.6 This decline in both the incidence of new 
cases and the mortality rate in adults can be attributed to the introduction of 
the three classes of antiretroviral drugs: nucleoside analogue antiretrovirals 
(AZT, ddI, ddC, 3TC, d4T),1 the non-nucleoside reverse transcriptase 
inhibitors (nevirapine, delavirdine, efavirer),8 and the protease inhibitors 
(crixivan, fortovase, norvir, viracept, and others).9 Even more significant 
are the facts concerning the perinatal transmission of HIY. In the United 
States, if HIV-infected women are not treated with AZT in pregnancy, 
roughly 25 percent of their infants will be HIV infected when born. If they 
are treated with AZT, the figure falls to 8 percent or lower. Between 1992 
and 1996, perinatally acquired AIDS cases declined 43% in the United 
States. In 1997, this trend continued with a 30% decline. lo Currently in the 
United States, roughly 8 percent of all infants born to HIV-infected women 
- fewer than 500 a year - are born infected. I I In the March 31, 1999 issue of 
The New England Journal of Medicine, data revealed that "a Caesarian 
alone reduces by half the risk of AIDS transmission during birth. An 
infected woman who has both a Caesarean ami treatment with AZT has 
only a 2% chance of infecting her child." 12 The success of the AZT 
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regi men on pregnant women and now the new data on the effects of 
Caesarian birth has given new hope to those women infected with HIV and 
to their children." 
The HIV infec tion rate in children is closely linked with the HIV 
infec tion rate in women. According to the CDC, "HIV transmission from 
mothers to child during pregnancy, labor and delivery or by breast-feeding 
has accounted fo r 9 L percent of all AIDS cases reported among United 
States children."' -l Stati sti cs show that women of color and their children 
have always been and continue to be disproportionately affected by the 
HIVepidem ic. In 1997. of the total 13, 105 AIDS cases reported among 
U.S. women. 10,458 (80~ ) were among African-A meri can and Hispanic 
women Y Of the 473 children reported with AIDS in 1998,402 (85%) 
were African-Ameri can and Hispanic.' 6 The reasons fo r the 
di sproportionate infection rate among women of colo r is due not only to 
inadequate perinatal HIV prevention efforts, and inadequate access and 
utili zation of prenatal care offered to women of color, but also to the sense 
of mi trust that both Afri can- Americans and Hispani cs have for the 
medical establi shment. 
Th is m istrust, especiall y by African-Americans, can be attributed to 
the events surrounding the Tuskegee Syphilis Study, whi ch was sponsored 
by the United States Public Health Service from J 932 to 1972. 17 However, 
after careful research and analys is, it appears that this study is but a marker 
fo r a more seri ous problem regarding rac ist attitudes and stereotypes that 
has ex isted for centuri es in the medical profession. Hi storian Alan Brandt 
argues that the medical professionals and researchers who directed and 
dev ised the Tuskegee Syphili s Study accepted the mainstream assumptions 
regard ing blac ks. 'There can be little doubt that the Tuskegee researchers 
regarded their subjects as less than human. As a result, the ethical canons 
of experimenting on human subjects were completely di sregarded."'8 The 
major impact of the Tuskegee story was that it authenticated a hi storically-
based pattern of medical mistreatment that has been well-known to the 
African-American communi ty th rough their own oral folkloric tradition. 
Thi s pattern shows that Afri can-Americans, and fo r that matter all 
minorit ies, were viewed as inherently inferior by the medical profession 
and pu bli c health agencies. Thi s has led to the lingering suspicion that 
medical profess ionals are not out to help minorities, but to use them as 
guinea pigs. '9 The influence of rac ism in the medi cal profession and a 
general di sregard toward those who are poor and vulnerable by the federal 
government has contribu ted to the " legacy of mistrust" in the minority 
communities and has had far-reaching consequences .20 One major 
consequence has been that women of color are suspicious of any 
government-sponsored programs that advocate testing or experimental 
medications. The result ha . been that a 1995 study that analyzed data on 
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approximately one-sixth of all HIV-exposed children born in the United 
States found that only about half (53%) received the benefit of a full AZT 
treatment regimen (for the mother during pregnancy and delivery and for 
the infant for the first six weeks after birth). According the CDC. "the 
main reason for babies not having the advantage of therapy was that more 
than one-fourth of the mothers (26%) did not get prenatal care."21 The 
majority of these mothers were women of color and a major reason for 
their lack of prenatal care is their suspicion of the medical establishment. 
Mandatory HIV testing of all pregnant women would not only save 
countless lives but would also conserve a large percentage of medical 
resources. The CDC estimates that without intervention, a 25 % mother-to-
infant transmission rate would result in the birth of an estimated 1,750 
HIV-infected infants annually in the United States, with a lifetime medical 
cost of $282 million. Researchers estimate that the annual cost of perinatal 
prevention is $67.6 million. This investment prevents 656 HIV infections 
and saves $105 .6 million in medical care costs alone, for a net cost-savings 
of $38.1 million annuallyY However, now with the new findings 
regarding the use of AZT and the effects of Caesarean birth, the number of 
lives saved and medical costs saved will increase. 
Critics of mandatory HIV testing for all pregnant women focus on 
three distinct areas. First, there are those critics who believe the focus of 
testing and treatment should be on the high-risk population. The problem 
with this is that HIV knows no boundaries . Women not in the high-risk 
population may also have been exposed unbeknownst to them. To single 
out specific groups, such as women of color, within the population could 
lead to discrimination and may force those most in need of HIV counseling, 
testing, and treatment to take less advantage of prenatal care than they do at 
present. It would also further the suspicion women of color feel toward the 
medical establishment. Second, some critics argue that if HIV testing 
becomes mandatory for all pregnant women it will eliminate or at least 
decrease the counseling that is associated presently about HIV and AIDS. 
Mildred Williamson, president of the AIDS Policy Center for Children , 
Youth and Families, stated, "Women must fully understand what an HIV 
test is, and the implications of a positive or negative result. It is not enough 
to simply inform women that they are being tested for HIV, and put the 
burden on them to ask questons."23 There is no reason to believe that there 
would be a decrease or an elimination of counseling on HIV and AIDS . 
Health care professionals have a professional and an ethical obligation to 
explain all tests and procedures to their patients as part of the principle of 
informed consent. To say that once mandatory testing becomes a federal 
guideline such counseling will cease to exist or the amount of counseling 
will decrease seems to question the professionalism and integrity of 
physicians. Third, some critics are concerned about protecting the privacy 
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of prospective mothers, especially regarding the documentation of HIV 
test results. The American Medical Association has adopted key principles 
regarding the patient 's right to privacy and the confidentiality of medical 
records. 
1) That there exists a basic right of patients to pri vacy of their 
medical information and records, and that this right should be 
explicitly acknowledged; 
2) That pati ents' pri vacy should be honored unless waived by 
the patient in a meaningful way (i.e. , informed, noncoercive) 
or in rare instances of strongly countervailing public interest 
and 
3) That information di sclosed should be limited to that 
information, portion of the medical record, or abstract 
necessary to fulfill the immediate and specific purposeY 
It is possible that the privacy of a pregnant woman might be violated. 
However, with various guidelines and safeguards in place, that medical 
records cannot be used without the informed consent of the patient, and 
with additional legi slation being proposed to protect the privacy of HIV 
and AIDS patients, these concerns can be addressed in a way that would 
offer reasonable protection. 
The practical concerns regarding mandatory testing of all pregnant 
women appear to be surmountable. From an ethical standpoint, however, 
thi s is a far more complex and controversial issue. Both sides in thi s 
debate appear to have legitimate concerns that they believe can be 
supported ethically. It must be determined which arguments are more 
convincing from an ethical point of view in the face of such a devastating 
crisis. 
Ethical Analysis 
The ethical controversy surrounding the debate over mandatory HIV 
testing of all pregnant women has taken on a sense of urgency because 
every day we delay in implementing this policy more children wi ll be born 
infected with HIV and more women, unaware that they are HIV-infected, 
will not only go untreated but may also infect others through sexual contact 
or intravenous drug injection. Proponents of mandatory HIV testing, such 
as Dr. Marie McCormick, director of Maternal and Child Health at the 
Harvard School of Public Health, argue that "we have the tools to prevent 
HIV infection in newborns and we must make sure they are available to 
everyone."25 The benefits of mandatory testing in preventing HIV 
infection to newborns and better care for infected mothers and their 
children can all be achieved at a cost to the country that is far below what 
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we spend today on treatment for infected individuals. This utilitarian 
argument is quite convincing, considering the devastating effect the AIDS 
epidemic has had on the allocation of medical resources both nationally 
and internationally. Time is of the essence for this public health issue and 
concern for the "common good" must be a priority. Opponents argue that 
mandatory testing will violate the basic human right of privacy. The term 
"right to privacy" encompasses "our right to live our personal lives as we 
see fit, to control what may be done to our own bodies, and to limit what 
information others may obtain about our personal affairs."26 Opponents 
argue that a pregnant woman 's privacy could also be violated because there 
are not adequate safeguards in place to keep the results of such testing 
confidential. Therefore, mandatory testing could violate their privacy 
twice - first by testing against their will, and then by giving others access 
to the results. Finally, opponents argue that this issue brings to light the 
reality of the slippery slope argument. If we allow for mandatory testing of 
all pregnant women today, why not for all people tomorrow? What about 
mandatory testing for drugs, alcohol, genetic disorders , etc? The ethical 
ramifications are far-reaching. 
Society, in general, has always recognized that in our complex world 
there is the possibility that we may be faced with conflict situations that 
leave us with two options, both of which are nonmoral evilsY The time-
honored ethical principle that has been applied to these situations is called 
the principle of the lesser of the two evils. "When one is faced with two 
options, both of which involve unavoidable (nonmoral) evil, one ought to 
choose the lesser evil."28 According to bioethicist Richard McCormick, 
S.1. , 
The concomitant of either course of action is harm of some sort. 
Now in situations of thi s kind. the rule of Christian reason, if we are 
governed by the ordo bonorum, is to choose the lesser evil. This 
general statement is, it would seem, beyond debate: for the only 
alternati ve is that in conflict situations we should choose the greater 
evil, which is patently absurd. This means that all concrete rules and 
distinctions are subdsidiary to this and hence valid to the extent that 
they actually convey to us what is factually the lesser evil. ... Now, if 
in a conflict situation one does what is, in balanced Christian 
judgment (and in thi s sense "objectively") , the lesser evil , his 
intentionality must be said to be integral. It is in this larger sense that 
I would attempt to read Thomas Aquinas 's statement that moral acts 
"recipiunt speciem secundum id quod intenditur." Thus the basic 
category for conflict situations is the lesser evil, or avoidable/ 
unavoidable evil, or proportionate reason.19 
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Therefore, in a conflict situation, an individual may directly choose to do a 
nonmoral evil (violating a person's autonomy, privacy, confidentiality) as a 
means to a truly proportionate good end (preservation and protection of 
human life) :lo 
The principle of the lesser of two evils is applicable to the issue of 
mandatory HIV testing of all pregnant women because one is faced with 
two options, both of which involve unavoidable nonmoral evils. On the 
one hand, failure to allow for mandatory testing of all pregnant women 
would result in hundreds of innocent HIV-infected infants being born 
yearly, and hundreds of women remaining unaware of their HIV infection 
and thus unable to seek early treatment and to protect others from the 
possible transmission of this lethal disease. In addition, there is the loss of 
millions of dollars in medical care costs annually as scientific data has 
shown. On the other hand, allowing for mandatory testing would violate a 
pregnant woman 's ri ght to privacy by testing against her will, and also 
could possibly violate her privacy by giving others possible access to the 
resul ts. 
The direct intention of mandatory HIV testing of all pregnant women 
is to protect and preserve human life and to encourage social support, 
professional counseling and medical care. Studies have shown that the 
hi ghest incidence of AIDS cases among women reported in the United 
States is among women of color. The direct intention of mandatory testing 
is to protect and preserve the lives of the most vulnerable, that is, the poor 
and the minorities, by stopping the spread of HI V transmission to innocent 
newborns and seeki ng immediate medical attention for infected mothers. 
However, in the process of protecting and preserving human life, which 
benefits the common good, the pregnant woman 's autonomy is violated. 
One would hope that all pregnant women would voluntarily agree to HIV 
testing, but this is not always possible and has not been a reality. The 
linchpin for resolving which option is the lesser of two evils rests on 
whether or not there is a proportionate reason for allowing mandatory 
testing of all pregnant women. 
Proportionate reason refers to a specific value and its relation to all 
elements (including nonmoral evils) in the action .31 The specific value in 
all owing for mandatory testing is to protect and preserve human life by 
preventing the lethal transmission of HIV to innocent newborns and 
getti ng immediate medical treatment for the infected mothers. The 
nonmoral ev il , which is the result of trying to achieve this value, is the 
violation of the pregnant woman 's right to privacy. The ethical question is 
whether the value of protecting and preserving human life outweighs the 
nonmoral evil of violating a woman 's right to privacy? To detennine if a 
proper re lationship exists between the specific value and the other 
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elements of the act, ethicist Richard McCormick, S.J. proposes three 
criteria for the establishment of proportionate reason : 
1) The means used will not cause more harm than necessary to 
achieve the va lue. 
2) No less harmful way ex ists to protect the value. 
3) The means used to achieve the value will not undermine ir. '2 
The application of McCormick's criteria to mandatory HN testing of 
pregnant women supports the argument that there is a proportionate reason 
for allowing this testing . First, scientific data has proven that mandatory 
HIV testing of all pregnant women will save the li ves of hundreds of 
innocent children and will prolong the lives of those determined to be 
infected if immediate medical treatment is begun. Voluntary HIV testing 
of pregnant women has helped lower the number of children with 
perinatally acquired AIDS by 43%. In addition, the CDC has estimated 
this would yield a net savings in medical costs and resources of $38. 1 
million annually.}} With the present state of health care costs skyrocketing, 
this savings would certainly benefit the common good." It is apparent that 
the means used will cause more good than harm, and will cause less harm 
than necessary to protect and save lives. 
Second, at present, there does not appear to be an alternative that is 
as effective as mandatory testing. It is true that other means ex ist, such as 
the federal guidelines that call for routine counseling of all pregnant women 
about HIV and offering them an HIV test. The result has been a 43 percent 
decrease in perinatal HIV transmission, which is an impressive decline. 
With additional education and more access to and utilization of prenatal care 
these statistics may even improve. However, the CDC statistics have shown 
that the highest rate of AIDS infections among women in the United States 
is among women of color. The barriers preventing women of color from 
seeking prenatal care and thus voluntarily agreeing to HIV testing are great. 
There is the "legacy of mistrust" which exists among the minority 
communities toward the medical establishment, the health care di sparities 
which presently exist among the minority population, and the lack of 
adequate HIV education. Despite the success of the present federal 
guidelines, even the American Medical Association (AMA) supports the 
position that "there should be mandatory HIV testing of all pregnant women 
and newborns with counseling and recommendations for appropriate 
treatments. "3~ Opponents to mandatory testing believe these baniers can be 
eliminated with education and increased access to prenatal care. However, 
as we wait for this to be accomplished, thousands of children will become 
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HIV infected, women who are HIV infected will be unaware of this fact 
and not seek appropriate treatment, and because they are unaware of their 
status, they have the potential to pass this disease onto many others. 
Voluntary HIV testing is less harmful , but it does not protect and preserve 
the value of human life. 
Third, mandatory testing does not undermine the value of human 
life. One can argue convincingly that the intention of mandatory HIV 
testing of pregnant women is to save human lives. Mandatory testing will 
not only save the lives of countless newborns but will allow thousands of 
women who are unaware of their HIV status to begin treatments that may 
save their lives and the lives of others they could possibly infect in the 
future. In the process, there is the possibility that punitive effects could 
result from mandatory testing. If the federal guidelines are changed, will 
they require mandatory reporting of HIV test results? 
The fear of discrimjnation is a real threat. There have been cases in 
the past when individuals have lost employment and medical insurance 
when employers and/or insurers have learned of an employee's HIV positive 
test results. However, proponents argue that mandatory testing results could 
be kept confidential with the proper procedures in place. The 1996 Health 
Insurance Portability and Accountability Act requires that the U.S. 
Department of Health and Human Services recommend to Congress a means 
for protecting individually identifiable information and establishing 
penalties for wrongful disclosure of such confidential data. The Department 
of Health and Human Services made such privacy recommendations to 
Congress for review on September II , 1997.35 The New York Times 
reported that as of January 1999, six bills relating to medical records were 
privately circulating in Congress.J6 
The purpose of mandatory testing is to save lives and it has been 
proven scientifically to be effective. This is a public health issue that must 
be addressed because innocent lives are being lost. It seems clear that there 
is a proportionate reason for the federal government to change its guidelines 
regarding mandatory HIV testing of all pregnant women. Such testing 
contributes to the well-being of the pregnant mothers, to the well-being of 
their newborns, to those who could be infected through contact with the 
undiagnosed, and by lowering medical costs to society as a whole over time. 
Therefore, it is ethically justified under the principle of proportionate reason 
for the federal government to change the guidelines regarding mandatory 
HIV testing for all pregnant women in the United States. Mandatory testing 
of all pregnant women is the lesser of two evils because the greater good is 
promoted in spite of the potential for evil consequences. 
Finally, from an ethical perspective, opponents argue that allowing 
mandatory HIV testing of pregnant women will set a legal precedent which 
could have dire consequences in the future. The slippery slope argument 
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suggests that if particular precedents are accepted, then certain 
consequences will follow as a matter of due course. By setting federal 
guidelines that allow for mandatory testing in the case of all pregnant 
women, what would stop the federal government from establishing similar 
guidelines in the future for mandatory HIV testing for all people or for 
genetic di seases? Certainly the same ethical arguments could be used to 
justify both types of mandatory testing. Physical harm could be averted , 
treatments could be initiated sooner rather than later, and preventive care is 
certainly less costly than waiting for the di sease to manifest itself. This is 
a valid argument, but it is an argument that could be used in any scenario. 
With every medical treatment there is always the potential for abuse. But 
because the potential is present does not mean it has to become a reality. 
Being aware of the possibility of abuse can be the impetus for safeguards 
which can be put in place to prevent similar abuses in the future. Because 
something can be abused does not mean it should be avoided. Instead, it 
should be an opportunity to address such weaknesses to avoid future 
negative ramifications. 
Conclusion 
I believe that mandatory HIV testing of all pregnant women in the 
United States is both a necessary and a vital part of a broader 
comprehensive strategy for preventing the spread of AIDS. After reviewing 
all the pertinent scientific data it is clear that mandatory HIV testing of all 
pregnant women would save thousands of human lives - mothers, newborns 
and others who could be infected as a result of these women not being 
aware of their HIV status. It is apparent that voluntary HIV testing has 
made some valuable inroads in decreasing perinatal HIV transmission, but 
the statistics showing the disproportionate rate of HIV infection among 
women of color are not very promising. Numerous barriers presently exist 
that cause women of color not to have access to or utilize prenatal care. To 
eliminate these barriers will take years, if elimjnation is possible at all. In 
the process, countless newborns will become HIV infected and infected 
mothers will fail to seek appropriate treatment and may even spread the 
disease to others, all because they are unaware of their HIV status. If we as 
a nation believe that the life of every person is sacred and should be treated 
with dignity and respect, especially the lives of the most vulnerable, then 
we must support what we believe is the greater good to protect and 
preserve human life. This does not mean that we should not continue to 
explore new ways to encourage voluntary HIV testing of all people. It 
does mean that if this is the best method available at the present time to 
protect the lives of innocent people, we must utilize it to its fullest capacity. 
It appears that the opponents to mandatory testing are say ing the right to 
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privacy and autonomy is a greater good than the preservation of human 
life. The AIDS virus is a runaway epidemic and as Dr. Peter Piot, head of 
the United Nations AIDS Program has stated, the time is now for us to 
embrace not only a new realism but also a new sense of urgency if we are 
going to combat this dreaded killer. 37 We cannot allow fears of future 
ramifications and an absolute sense of privacy to stand in the way of 
fighting this lethal disease. Human lives hang in the balance. If the 
protection and preservation of human life is a priority in this country, then 
it is time to allow for mandatory HIV testing of all pregnant women, before 
it is too late for those who are the most vulnerable. 
Postscript 
On July IS, 1999, The New York Times reported that the drug 
nevirapine had cut the risk of mother-to-child transmission of HIV to 13% 
from 25% for the standard course of AZT in developing countries. 
Nevirapine, a drug used in combination "cocktail" treatments, has been 
marketed in the United States for treatment of HIV since 1996. The more 
practical therapy comes from substituting one marketed drug, nevi rapine, 
for the standard drug, AZT. The treatment calls for both a mother and her 
infant to take nevirapine just one time - a mother takes the pill during 
labor, and her baby is fed the drug as a syrup once during the first three 
days of life. The cost of the two doses of nevirapine is $4, compared with 
$268 for the AZT regimen now used in developing countries. American 
and Ugandan researchers are planning another study to see if it would be 
more effective to give nevirapine to mother and infant for longer periods. 
Also, a continuing study in the United States and Europe aims to determine 
if adding nevi rapine to standard regimens will further lower the 
transmission rate of HIV from mother to child.38 
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